Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients

NCT04991038 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-10-21

No results posted yet for this study

Summary

Compare the safety and efficacy of the DAISE to stent retrievers in the treatment of acute ischemic stroke

Conditions

  • Stroke
  • Stroke, Ischemic
  • Stroke, Acute
  • Cerebrovascular Disorders
  • Cerebrovascular Accident

Interventions

DEVICE

DAISe Device

Thrombectomy using the DAISE device

DEVICE

Trevo or Solitaire

Thrombectomy using TREVO or Solitaire device

Sponsors & Collaborators

  • MIVI Neuroscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Adnan Siddiqui, MD, PhD · UB/Kaleida Health

  • Brian Jankowitz, MD · U Penn Medical Center

  • Luvas Elijovich, MD · University of Tennessee Health Sciences Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2024-09-30
Completion
2024-09-30
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04991038 on ClinicalTrials.gov